Special Issue "Adhesion and Integrins"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (30 October 2012)
Prof. Dr. Kairbaan Hodivala-Dilke
The Adhesion and Angiogenesis Laboratory, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London
Interests: Adhesion and Integrins, Tumour Angiogenesis, Cancer Cell Biology, Metastasis and Invasion and Breast Cancer
Cancer initiation, growth, progression and metastasis are all stages of the disease that involve changes in both cell-cell and cell-matrix adhesion. Such changes occur not only the tumour cell compartment but also in the stromal compartment, with changes in the adhesive capacity of immune cells, tumour associated fibroblasts, endothelial cells and so on. It is increasing evident that blockade of such adhesion molecules may have therapeutic value. The special issue of Cancers on ‘Adhesion and Integrins’ will include original research articles and review articles on the influence of adhesion molecules in cancer development and how we can exploit such changes for therapeutic advance.
Prof. Kairbaan Hodivala-Dilke
- Immune infiltration
Review: RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis
Cancers 2012, 4(4), 1106-1145; doi:10.3390/cancers4041106
Received: 23 August 2012; in revised form: 9 October 2012 / Accepted: 22 October 2012 / Published: 26 October 2012| Download PDF Full-text (714 KB) | View HTML Full-text | Download XML Full-text
Cancers 2013, 5(1), 27-47; doi:10.3390/cancers5010027
Received: 5 December 2012; in revised form: 9 January 2013 / Accepted: 11 January 2013 / Published: 15 January 2013| Download PDF Full-text (234 KB) | View HTML Full-text | Download XML Full-text
Last update: 25 February 2014